Unitat de Rinologia Pediàtrica, Otorhinolaringology Department, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.
Unitat de Rinologia i Clínica de l'Olfacte, Otorhinolaringology Department, Hospital Clínic, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain.
Pediatr Allergy Immunol. 2017 Aug;28(5):438-445. doi: 10.1111/pai.12724. Epub 2017 Jun 19.
We previously reported a higher prevalence of nasal obstructive disorders (NOD) in pediatric patients with persistent allergic rhinitis (PER) not responding to medical treatment. The aim of this study was to determine the impact of NOD on quality of life (QoL) in this population.
Real-life prospective study including 142 patients (41 children, 6-11 years old and 101 adolescents, 12-17 years old) with moderate and severe PER. After 2 months of medical treatment (intranasal steroids and antihistamines), patients were asked whether their symptoms had improved (yes/no) and classified accordingly in R, responders and NR, non-responders. Nasal symptoms (visual analog scale, VAS), NOD (nasal endoscopy), and QoL (PRQLQ, AdolQRLQ) were also assessed.
Sixty-nine adolescents and 24 children were included in the NR group. NR presented worse QoL overall scores in adolescents (3.16±1.1 vs 1.63±0.99; P=.00001) and children (2.19±0.82 vs 1.51±0.77, P=.02). Medical treatment failure was associated with worse outcomes in QoL (adolescents OR: 1.6, P<.0001; children OR: 1.04, P=.036). Female adolescents presented worse QoL scores than males (3.19 vs 2.36, P=.001). The presence of obstructive septal deviation (OR: 1.02, P=.005), obstructive turbinate hyperplasia (OR: 1.03, P=.0006), and coexistence of both (OR=2.06, P=.001) was associated with worse QoL in adolescents. A strong and highly significant correlation was found between nasal symptoms VAS and QoL.
The presence of NOD, particularly in adolescents, is associated with poor QoL outcomes. Assessment of NOD in pediatric PER should be considered an essential approach to determine the response to treatment and its impact on patient's QoL.
我们之前报道过,在对药物治疗无反应的持续性变应性鼻炎(PER)的儿科患者中,鼻腔阻塞性疾病(NOD)的患病率更高。本研究的目的是确定在该人群中 NOD 对生活质量(QoL)的影响。
这是一项真实前瞻性研究,纳入了 142 名(41 名儿童,6-11 岁和 101 名青少年,12-17 岁)中重度 PER 患者。在接受 2 个月的药物治疗(鼻内皮质类固醇和抗组胺药)后,询问患者症状是否改善(是/否),并据此将患者分为 R(有反应者)和 NR(无反应者)。还评估了鼻腔症状(视觉模拟量表,VAS)、NOD(鼻内镜)和 QoL(PRQLQ,AdolQRLQ)。
NR 组中包括 69 名青少年和 24 名儿童。NR 组青少年的整体 QoL 评分更差(3.16±1.1 比 1.63±0.99;P=.00001)和儿童(2.19±0.82 比 1.51±0.77,P=.02)。治疗失败与 QoL 结局较差相关(青少年 OR:1.6,P<.0001;儿童 OR:1.04,P=.036)。女性青少年的 QoL 评分比男性更差(3.19 比 2.36,P=.001)。鼻中隔偏曲(OR:1.02,P=.005)、鼻甲过度增生(OR:1.03,P=.0006)和两者并存(OR=2.06,P=.001)与青少年 QoL 较差相关。VAS 鼻腔症状与 QoL 之间存在强且高度显著的相关性。
NOD 的存在,特别是在青少年中,与较差的 QoL 结局相关。在儿科 PER 中评估 NOD 应被视为确定治疗反应及其对患者 QoL 影响的重要方法。